Paper39474609
Willingness to pay and price elasticity of demand for long-acting injectable cabotegravir among men who have sex with men in Guangxi, China.
Chen S and 11 others. Front Pharmacol, 2024. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Willingness to pay and price elasticity of demand for long-acting injectable cabotegravir among men who have sex with men in Guangxi, China. Papers, record 39474609. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39474609
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Willingness to pay and price elasticity of demand for long-acting injectable cabotegravir among men who have sex with men in Guangxi, China.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31340482 | Willingness to Use and Adhere to HIV Pre-Exposure Prophylaxis (PrEP) among Men Who Have Sex with Men (MSM) in China. | Int J Environ Res Public Health | 2019 | https://conductscience.org/library/papers/31340482 | PubMed |
| 2 | 34142274 | Preferences for Current and Future PrEP Modalities Among PrEP-Experienced Gay and Bisexual Men in Australia. | AIDS Behav | 2022 | https://conductscience.org/library/papers/34142274 | PubMed |
| 3 | 28176168 | A Global Estimate of the Acceptability of Pre-exposure Prophylaxis for HIV Among Men Who have Sex with Men: A Systematic Review and Meta-analysis. | AIDS Behav | 2018 | https://conductscience.org/library/papers/28176168 | PubMed |
| 4 | 36631515 | Awareness and use of HIV pre-exposure prophylaxis and factors associated with awareness among MSM in Beijing, China. | Sci Rep | 2023 | https://conductscience.org/library/papers/36631515 | PubMed |
| 5 | 33611697 | Slow Uptake of PrEP: Behavioral Predictors and the Influence of Price on PrEP Uptake Among MSM with a High Interest in PrEP. | AIDS Behav | 2021 | https://conductscience.org/library/papers/33611697 | PubMed |
| 6 | 32178657 | Low willingness to pay for pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) in China. | BMC Public Health | 2020 | https://conductscience.org/library/papers/32178657 | PubMed |
| 7 | 37139146 | Analysis of Knowledge Level and Use of Antiretroviral Pre-Exposure and Post-Exposure Prophylaxis Among MSM - China, 2019-2022. | China CDC Wkly | 2023 | https://conductscience.org/library/papers/37139146 | PubMed |
| 8 | 29290075 | Expanding the Menu of HIV Prevention Options: A Qualitative Study of Experiences with Long-Acting Injectable Cabotegravir as PrEP in the Context of a Phase II Trial in the United States. | AIDS Behav | 2018 | https://conductscience.org/library/papers/29290075 | PubMed |
| 9 | 31842772 | Prepared for PrEP: preferences for HIV pre-exposure prophylaxis among Chinese men who have sex with men in an online national survey. | BMC Infect Dis | 2019 | https://conductscience.org/library/papers/31842772 | PubMed |
| 10 | 30870322 | Monitoring HIV Preexposure Prophylaxis Use Among Men Who Have Sex With Men in Washington State: Findings From an Internet-Based Survey. | Sex Transm Dis | 2019 | https://conductscience.org/library/papers/30870322 | PubMed |
| 11 | 31298662 | Changes in HIV Preexposure Prophylaxis Awareness and Use Among Men Who Have Sex with Men - 20 Urban Areas, 2014 and 2017. | MMWR Morb Mortal Wkly Rep | 2019 | https://conductscience.org/library/papers/31298662 | PubMed |
| 12 | 35148029 | Engagement in the pre-exposure prophylaxis (PrEP) cascade among a respondent-driven sample of sexually active men who have sex with men and transgender women during early PrEP implementation in Zimbabwe. | J Int AIDS Soc | 2022 | https://conductscience.org/library/papers/35148029 | PubMed |
| 13 | 39095714 | Potential healthcare resource use and associated costs of every 2 month injectable cabotegravir plus rilpivirine long-acting regimen implementation in the Spanish National Healthcare System compared to daily oral HIV treatments. | BMC Infect Dis | 2024 | https://conductscience.org/library/papers/39095714 | PubMed |
| 14 | 36991027 | Exploring preferences and decision-making about long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young sexual minority men 17-24 years old. | Sci Rep | 2023 | https://conductscience.org/library/papers/36991027 | PubMed |
| 15 | 27459164 | Willingness to Self-Pay for Pre-exposure Prophylaxis in Men Who Have Sex With Men: A National Online Survey in Taiwan. | AIDS Educ Prev | 2016 | https://conductscience.org/library/papers/27459164 | PubMed |
| 16 | 33468089 | Barriers to using HIV pre-exposure prophylaxis (PrEP) and sexual behaviour after stopping PrEP: a cross-sectional study in Germany. | BMC Public Health | 2021 | https://conductscience.org/library/papers/33468089 | PubMed |
| 17 | 28707025 | Interest in Long-Acting Injectable PrEP in a Cohort of Men Who have Sex with Men in China. | AIDS Behav | 2018 | https://conductscience.org/library/papers/28707025 | PubMed |
| 18 | 35255193 | Increasing awareness of HIV pre-exposure prophylaxis (PrEP) and willingness to use HIV PrEP among men who have sex with men: a systematic review and meta-analysis of global data. | J Int AIDS Soc | 2022 | https://conductscience.org/library/papers/35255193 | PubMed |
| 19 | 36632416 | Cabotegravir-Global Access to Long-Acting Pre-exposure Prophylaxis for HIV. | Open Forum Infect Dis | 2023 | https://conductscience.org/library/papers/36632416 | PubMed |
| 20 | 37823865 | Daily Oral HIV Pre-exposure Prophylaxis Among Young Men Who Have Sex With Men in the United States: Cost-saving at Generic Drug Price. | Clin Infect Dis | 2024 | https://conductscience.org/library/papers/37823865 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42426678 | Cost-effectiveness of concurrently available oral and long-acting injectable pre-exposure prophylaxis for preventing HIV infections among men who have sex with men in eastern China: A modelling study. | BMC Public Health | 2026 | https://conductscience.org/library/papers/42426678 | PubMed |
| 41350365 | The unseen impact of affordability: copayment sensitivity for long-acting PrEP among MSM in six European Countries, October 2023-April 2024. | Sci Rep | 2025 | https://conductscience.org/library/papers/41350365 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39474609
GET https://conductscience.org/api/papers/v1/39474609/references?page=2